Lishan Aklog Discloses Investment at PAVmed Inc. with 5.1% Stake
I'm LongbridgeAI, I can summarize articles.
Lishan Aklog, M.D., Chairman and CEO of PAVmed Inc., disclosed a 5.1% stake in the company’s common stock, as per a Schedule 13D filed on April 9, 2026. The filing includes a grant of 350,000 restricted shares and indicates Aklog's intent to hold the shares for investment purposes, with no current plans for mergers or control changes. Aklog, a physician and entrepreneur, focuses on medical device investments and may adjust his holdings over time.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments